ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD. Zylox-Tonbridge Medical Technology Co., Ltd. Share Price
Equities
2190
CNE100004JD2
Medical Equipment, Supplies & Distribution
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.56 HKD | +2.13% |
|
+8.31% | -15.11% |
| 03-22 | Zylox-Tonbridge Shrinks Loss by 31% in Fiscal 2023 | MT |
| 03-21 | Zylox-Tonbridge Medical Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Sales 2023 | 528M 72.84M 570M 5.82B | Sales 2024 * | 764M 105M 825M 8.42B | Capitalization | 3.13B 433M 3.39B 34.55B |
|---|---|---|---|---|---|
| Net income 2023 | -78M -10.77M -84.27M -860M | Net income 2024 * | 72M 9.94M 77.79M 794M | EV / Sales 2023 | 7.02 x |
| Net cash position 2023 * | 1.05B 144M 1.13B 11.53B | Net cash position 2024 * | 994M 137M 1.07B 10.95B | EV / Sales 2024 * | 2.8 x |
| P/E ratio 2023 |
-47.1
x | P/E ratio 2024 * |
43.5
x | Employees | 765 |
| Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 32.19% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | +2.13% | ||
| 1 week | +8.31% | ||
| Current month | +8.98% | ||
| 1 month | +5.81% | ||
| 3 months | +3.53% | ||
| 6 months | -1.68% | ||
| Current year | -15.11% |
1 week
9.72
10.64
1 month
8.6210.64
Current year
8.6212.58
1 year
7.2014.66
3 years
7.2060.80
5 years
7.2060.80
10 years
7.2060.80
| Managers | Title | Age | Since |
|---|---|---|---|
Zhong Zhao
CEO | Chief Executive Officer | 58 | 05/11/12 |
Quan Wei Yuan
DFI | Director of Finance/CFO | 46 | 31/12/20 |
Ning Pan
CTO | Chief Tech/Sci/R&D Officer | 58 | 31/12/18 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Hong Ze Liang
BRD | Director/Board Member | 53 | 01/03/21 |
Yun Qiu
BRD | Director/Board Member | 61 | 01/03/21 |
Hui Wang
BRD | Director/Board Member | 52 | 31/10/15 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/04/24 | 10.56 | +2.13% | 41 000 |
| 26/04/24 | 10.34 | +0.98% | 64,500 |
| 25/04/24 | 10.24 | -2.48% | 66,500 |
| 24/04/24 | 10.5 | +3.96% | 129,000 |
| 23/04/24 | 10.1 | +3.59% | 205,500 |
Delayed Quote Hong Kong S.E., April 29, 2024 at 03:32 am
More quotes
Zylox-Tonbridge Medical Technology Co Ltd, formerly Zylox Medical Device Co Ltd, is a China-based company mainly engaged in the research and development of neurological and peripheral vascular interventional medical devices. The Company's main products include Thrombite Clot Retriever Device (Thrombite CRD) and Ultrafree Drug Coated PTA Balloon Catheter (Ultrafree DCB). The Company's products are sold to domestic and foreign markets.
Calendar
25/08/2024
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
9.571
CNY
Average target price
14.11
CNY
Spread / Average Target
+47.39%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -15.11% | 433M | |
| +12.07% | 128B | |
| -9.04% | 10.65B | |
| +0.91% | 8.82B | |
| +16.72% | 7.19B | |
| +25.15% | 4.99B | |
| +7.17% | 3.4B | |
| -1.36% | 3.03B | |
| -8.73% | 2.14B | |
| -10.15% | 2B |
- Stock Market
- Equities
- 2190 Stock
